Skip to content

The effects of filaggrin deficiency on sensitization patterns, severity and quality of life in patients with atopic eczema

The effects of filaggrin deficiency on sensitization patterns, severity and quality of life in patients with atopic eczema - FILATOP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35846
Enrollment
100
Registered
2012-02-03
Start date
2011-07-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dermatitis eczema

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patient has been diagnosed with atopic eczema by attending dermatologist

Exclusion criteria

Exclusion criteria: Patient is not willing to participate Patient does not speak or read Dutch Patient is younger than 18 years of age Patient can not be instructed

Design outcomes

Primary

MeasureTime frame
Main study parameter is the prevalence of sensitisation to specific inhalant allergens in correlation to filaggrin deficiency.

Secondary

MeasureTime frame
Secondary study parameters are the scores on symptom based and quality of life questionnaires and Raman-spectral variations, reflecting variations in molecular composition of the skin in AD.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)